PPA
LFCR icon

Parametric Portfolio Associates’s Lifecore Biomedical LFCR Stock Holding History

Parametric Portfolio Associates’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$241K Sell
20,825
-1,738
-8% -$19.4K ﹤0.01% 3370
2021
Q4 		$250K Buy
22,563
+6,878
+44% +$66.8K ﹤0.01% 3342
2021
Q3 		$145K Buy
+15,685
New +$171K ﹤0.01% 3485
2021
Q2 		– Sell
-22,918
Closed -$243K – 3581
2021
Q1 		$243K Buy
22,918
+3,233
+16% +$36.3K ﹤0.01% 3803
2020
Q4 		$214K Sell
19,685
-599
-3% -$6.19K ﹤0.01% 3741
2020
Q3 		$197K Buy
20,284
+923
+5% +$8.79K ﹤0.01% 3660
2020
Q2 		$154K Buy
19,361
+654
+3% +$6.75K ﹤0.01% 3696
2020
Q1 		$163K Sell
18,707
-5,183
-22% -$53.9K ﹤0.01% 3608
2019
Q4 		$270K Sell
23,890
-16,148
-40% -$172K ﹤0.01% 3618
2019
Q3 		$435K Buy
40,038
+21,448
+115% +$233K ﹤0.01% 3392
2019
Q2 		$174K Sell
18,590
-915
-5% -$9.24K ﹤0.01% 3762
2019
Q1 		$240K Buy
+19,505
New +$238K ﹤0.01% 3650
2017
Q4 		– Sell
-74,746
Closed -$968K – 3924
2017
Q3 		$968K Sell
74,746
-396
-0.5% -$5.22K ﹤0.01% 3067
2017
Q2 		$1.12M Sell
75,142
-42,886
-36% -$597K ﹤0.01% 2919
2017
Q1 		$1.42M Sell
118,028
-61,466
-34% -$778K ﹤0.01% 2677
2016
Q4 		$2.48M Sell
179,494
-45,047
-20% -$624K ﹤0.01% 2230
2016
Q3 		$3.01M Sell
224,541
-15,262
-6% -$185K ﹤0.01% 2028
2016
Q2 		$2.58M Sell
239,803
-18,309
-7% -$202K ﹤0.01% 2131
2016
Q1 		$2.71M Buy
+258,112
New +$2.83M ﹤0.01% 2143
2014
Q1 		– Sell
-30,758
Closed -$373K – 3849
2013
Q4 		$373K Sell
30,758
-6,093
-17% -$72.8K ﹤0.01% 3321
2013
Q3 		$450K Buy
36,851
+523
+1% +$7.3K ﹤0.01% 3165
2013
Q2 		$480K Buy
+36,328
New +$502K ﹤0.01% 3002

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parametric Portfolio Associates's LFCR Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Lifecore Biomedical (LFCR) stake by 7.7% in Q1 2022, selling an estimated $19.4K and leaving 20,825 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #3370.

Parametric Portfolio Associates first reported a position in LFCR in Q2 2013 and has held it in 22 quarters since. The position peaked at $3.01M in Q3 2016. 97 funds tracked by Wall St. Rank hold LFCR as of Q1 2022.

  • Parametric Portfolio Associates held 20,825 shares of Lifecore Biomedical worth $241K as of Q1 2022.
  • Parametric Portfolio Associates sold 1,738 Lifecore Biomedical shares in Q1 2022, an estimated $19.4K.
  • Lifecore Biomedical made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3370 holding.
  • Parametric Portfolio Associates first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 22 quarters since.
  • Parametric Portfolio Associates's Lifecore Biomedical position peaked at $3.01M in Q3 2016.
  • 97 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.